Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn’s disease

AIM: To investigate genetic factors that might help define which Crohn’s disease (CD) patients are likely to benefit from anti-tumor necrosis factor (TNF) therapy. METHODS: This was a prospective cohort study. Patients were recruited from a university digestive disease practice database. We included...

Descripción completa

Detalles Bibliográficos
Autores principales: Netz, Uri, Carter, Jane Victoria, Eichenberger, Maurice Robert, Dryden, Gerald Wayne, Pan, Jianmin, Rai, Shesh Nath, Galandiuk, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Prospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526766/
https://www.ncbi.nlm.nih.gov/pubmed/28785150
http://dx.doi.org/10.3748/wjg.v23.i27.4958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526766/
https://www.ncbi.nlm.nih.gov/pubmed/28785150
http://dx.doi.org/10.3748/wjg.v23.i27.4958

Ejemplares similares